Volume 91 Issue 49 | pp. 25-27
Issue Date: December 9, 2013

Stem Cell Exploitation

Unproven therapies, cosmetics present challenges for regulators worldwide
Department: Government & Policy | Collection: Life Sciences, Safety
News Channels: Biological SCENE
Keywords: stem cells, FDA, cosmetics, biologic drugs

Hundreds of clinics have sprung up, primarily in developing countries, claiming to provide “effective, routine, and low-risk” stem cell therapies to cure nearly any disease imaginable. Similarly, cosmetics, such as facial creams and serums, as well as liquid oral supplements and capsules, have flooded the marketplace, claiming to provide antiaging effects by enhancing stem cell production.

This proliferation of stem-cell-based products and therapies during the past five years has left government agencies around the world . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society